Last edition
News about Global Pharma
US FDA approval: Lupin can now market its generic drugs
In its recent statement Lupin has said that it received approval from the US health regulator to market Efinaconazole topical solution, used to treat fungal toenail infections, in the American market
Global Pharma | 07/03/2022 | By Darshana | 342
UK-India innovation centre kick-starts to create a ?hot spot? for sustainable cooling innovation
The Centre of Excellence in Sustainable Cooling and Cold-Chain will conduct state-of-the-art applied research in food and vaccine distribution, supporting the roll-out of affordable, energy resilient, low emission cold-chain systems in India
Global Pharma | 04/03/2022 | By Darshana | 743
As US FDA lifts clinical hold, Covaxin to be evaluated as COVID-19 vaccine candidate in US
Covaxin (BBVI52), which has been developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), is an investigational vaccine candidate product in the US
Global Pharma | 22/02/2022 | By Darshana | 243
he Ascent merger offers access to an attractive client portfolio and adds substantially to PharmaLex?s global footprint, not only in the Japanese market but in other key markets throughout East and Southeast Asia. With deep roots in Asia, Ascent can act as a true partner in the region and, through the merger with PharmaLex
Global Pharma | 10/02/2022 | By Darshana | 788
DGFT removes restrictions on syringe exports
The government has removed restrictions on exports of syringes with immediate effect, according to a notification. Restrictions were imposed last year in the wake of the COVID-19 pandemic
Global Pharma | 04/02/2022 | By Darshana | 243
Aurobindo and Unichem recall products in US market
Aurobindo Pharma and Unichem Laboratories are recalling different products in the US market, the world's largest market for medicines, due to manufacturing issues. As per the latest enforcement report issued by the US Food and Drug Administration (FDA), Aurobindo's US-based unit is recalling 7,296 containers of hypertension drug Carvedilol tablets
Global Pharma | 08/12/2021 | By Darshana | 308
Syntegon enters strategic partnership with Bayer
Syntegon (formerly Bosch Packaging Technology), has entered a strategic partnershop with Bayer for the development of new continuous manufacturing processes for oral solid dosage (OSD) forms. The cooperation is based on the Xelum platform developed by the Syntegon subsidiary
Global Pharma | 18/11/2021 | By Darshana | 280
US FDA issues final order and guidance on surgical staplers and staples for internal use
The agency issued a final order reclassifying surgical staplers for internal use from Class I (general controls) to Class II (special controls) and requiring them to undergo premarket review. As a result, surgical staplers for internal use will be subject to more stringent regulatory requirements, including requiring premarket notification and special
Global Pharma | 11/10/2021 | By Darshana | 319
Sandoz enters commercialization pact with Bio-Thera Solutions for biosimilar bevacizumab
Sandoz, a Novartis division, announced that it has entered into a commercialization agreement with Bio-Thera Solutions, Ltd. for biosimilar bevacizumab (BAT1706)
Global Pharma | 09/09/2021 | By Darshana | 275
The US Food and Drug Administration (FDA) approved the first covid-19 vaccine. The vaccine has been known as the Pfizer-BioNTech Covid-19 vaccine, and will now be marketed as Comirnaty (koe-mir'-na-tee), for the prevention of Covid-19 disease in individuals 16 years of age and older
Global Pharma | 24/08/2021 | By Darshana | 225
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy